Account
Infectious assigned creative mandate for Pinnacle Neelanchal
MUMBAI: Infectious has been signed on as the communications partner for Pinnacle Groups new residential project in Sus – Neelanchal.
The agency will be responsible for the branding, positioning and all its marketing and communication requirements.
The multi-media campaign was launched on 25 September. Infectious co-founder and director Ramanuj Shastry said, “It will be a pleasure working with the Pinnacle Group as they are thorough professionals. The attention to detail and thought given to the Pinnacle Neelanchal project is simply awe-inspiring. We look forward to doing some truly engaging work with them.”
Added Infectious co-founder and director Nisha Singhania, “Neelanchal is an extremely thought through project. Its features are not just nice to have amenities, but ones that keep people and their needs at the core. The team at Pinnacle Group is dynamic and believe in perfection. It is our pleasure to work on this project and we look forward to doing some great work for them.”
The Pinnacle Group is a Pune based real estate company, which was started in 1996. Since then they have completed more than 25 redevelopment projects and have more than 700 satisfied homeowners. Neelanchal is its latest offering. It is a 16 acre residential project, coming up in Sus.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
